宫颈特殊染色法、液基薄层细胞学及人乳头瘤病毒检测对宫颈癌前病变的应用价值分析. (Chinese)

Analysis of Application value of Folate Receptor Mediated Cervical Special Staining, Thin-Cytologic Test and Human Papilloma Virus Test in Cervical Precancerous Lesions. (English)

Objective: To explore the application value of folate receptor mediated cervical special staining (FRD), Thin-Cytologic test (TCT) and human papilloma virus (HPV) tests in cervical precancerous lesions. Methods: 1794 women screened for cervical precancerous lesions in our Hospital were selected. All women received FRD, TCT and HPV tests.Pathological result was assigned as positive standard, and the diagnostic efficiency of three different detection methods and joint detection were compared and analyzed. Results: 111 cases were positive in pathological biopsy, the detection rate was 6.19% .114 positive cases detected by FDR, the detection rate was 6.35%, the missed diagnosis rate was 16.22%.115 positive cases detected by TCT, the detection rate was 6.41%, the missed diagnosis rate was 19.82%. 108 positive cases detected by HPV, the detection rate was 6.02%, the missed diagnosis rate was 19.82%. There was no significant difference in relevance ratio between FRD detection and TCT, HPV detection (P>0.05). For FRD, sensitivity was 83.78 %, specificity was 98.75%, positive predictive value was 81.58% and negative predictive value was 98.93% . For TCT, sensitivity was 80.18%, specificity was 98.46%, positive predictive value was 77.39% and negative predictive value was 98.69%. For HPV test, sensitivity was 80.18%, specificity was 98.87%, positive predictive value was 82.41% and negative predictive value was 98.70%. For FRD joint detection of FRD, TCT, HPV, the sensitivity was 93.69%,the specificity is 99.52%, positive predictive value was 92.86%, and negative predictive value was 99.58%. There were significant differences in sensitivity, positive predictive value between joint detection of FRD, TCT, HPV and FRD, TCT, HPV separately(P<0.05). Conclusions: The diagnostic efficacy of FRD, TCT and HPV for cervical precancerous lesions is comparable, while the diagnostic efficiency of joint detection of FRD, TCT, HPV is superior to each other. [ABSTRACT FROM AUTHOR]

目的:探讨宫颈特殊染色法(FRD)、液基薄层细胞学(TCT)及人乳头瘤病毒(HPV)检测对宫颈癌前病变筛查的应用价值。方法:选取2015年1月～2018年1月于我院行宫颈癌筛查的1794例妇女作为研究对象,所有研究对象均接受FRD、TCT、HPV检测,以经阴道镜取样活检结果为阳性标准,对比分析三种不同检测方法以及联合检测的诊断效能。结果:病理科活检检出阳性111例,检出率为6.19%;FDR检测检出阳性114例,检出率为6.35%,漏诊率为16.22%;TCT检测检出阳性115例,检出率为6.41%,漏诊率为19.82%;HPV检测检出阳性108例,检出率为6.02%,漏诊率为19.82%;FRD检测与TCT、HPV检测的检出率比较差异无统计学意义(P>0.05)。FRD检测敏感度为83.78%,特异度为98.75%,阳性预测值为81.58%,阴性预测值为98.93%;TCT检测敏感度为80.18% 特异度为98.46%,阳性预测值为77.39%,阴性预测值为98.69%;HPV检测敏感度为80.18%,特异度为98.87%,阳性预测值为82.41%,阴性预测值为98.70%;FRD、TCT、HPV联合检测敏感度为93.69%,特异度为99.52%,阳性预测值为92.86%,阴性预测值为99.58%;FRD、TCT、HPV联合检测与FRD、TCT、HPV单独检测的敏感度、阳性预测值比较差异具有统计学意义(P<0.05)。结论:FRD、TCT、HPV检测对宫颈癌前病变的诊断效能相当,而FRD、TCT、HPV联合检测的诊断效能优于各方法单独检测. [ABSTRACT FROM AUTHOR]

Copyright of Progress in Modern Biomedicine is the property of Publishing House of Progress in Modern Biomedicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)